ÂÜÀòÂÒÂ×

Mathilde TRESCARTE has extensive experience in regulatory affairs, with their most recent role being Head of Regulatory Affairs at Rofim since July 2022. Prior to this, they worked as a Regulatory Affairs Manager at Horus Pharma from October 2021 to June 2022. Mathilde also served as a Specialist in Regulatory Affairs Submission, X-Products at GSK BIOLOGICALS from January 2018 to November 2021. Before joining GSK BIOLOGICALS, Mathilde worked as a Consultant in Regulatory Affairs for GSK Biologicals at AIXIAL from September 2016 to December 2017. Mathilde also gained valuable experience as a Trainee at LFB from March 2016 to August 2016, at CHU Gabriel MONTPIED from March 2015 to July 2015, and at Laboratoires Théa from October 2014 to December 2014.

Mathilde Trescarte completed their undergraduate studies at Universite d'Auvergne, where they obtained a degree in Pharmacy from 2009 to 2016. Following that, they pursued a Master's degree in International Drug Development and Registration - Pharmacy at Paris-Sud University (Paris XI) from 2015 to 2016.